ZEVRA THERAPEUTICS, INC. (ZVRA) › Capital ExpendituresZEVRA THERAPEUTICS, INC. (ZVRA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2013: $51.0K2014: $47.0K2015: $135.0K2016: $643.0K2017: $181.0K2018: $21.0K2019: $26.0K2020: $33.0K2021: $102.0K2022: $93.0K2023: $296.0K2024: $02025: $835.0K$835.0K2013Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$835.0K—2024$0-100.0%2023$296.0K+218.3%2022$93.0K-8.8%2021$102.0K+209.1%2020$33.0K+26.9%2019$26.0K+23.8%2018$21.0K-88.4%2017$181.0K-71.9%2016$643.0K+376.3%2015$135.0K+187.2%2014$47.0K-7.8%2013$51.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share